Frontlight ResearchEarly access
Trial site
Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis3 trials
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Ionis Pharmaceuticals, Inc.2 trials
- Eidos Therapeutics, a BridgeBio company1 trial
- Karyopharm Therapeutics Inc1 trial
Running trials
Enrolling by invitation
Active, not recruiting
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026